What are the treatment options for cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cluster Headache Treatment

For acute cluster headache attacks, initiate high-flow oxygen at 100% and 12 L/min via non-rebreather mask for 15 minutes, or subcutaneous sumatriptan 6 mg; for prevention of episodic cluster headache, galcanezumab is the first-line prophylactic agent with the strongest evidence. 1, 2

Acute Treatment Algorithm

First-Line Options (Choose Based on Availability and Patient Preference)

  • High-flow oxygen therapy is the primary acute treatment: administer 100% oxygen at 12 L/min via non-rebreather mask for 15 minutes, which provides pain relief in 78% of patients compared to 20% with placebo 1, 3

  • Subcutaneous sumatriptan 6 mg provides rapid relief with 49% of patients pain-free within 10 minutes and 74-75% within 15 minutes 1

  • Intranasal zolmitriptan 10 mg serves as an alternative to subcutaneous sumatriptan for patients who cannot tolerate injections 1

Critical Pitfall to Avoid

  • Oxygen flow rates below 12 L/min are insufficient—proper equipment with adequate flow capacity is essential for efficacy 1, 4

  • Home oxygen concentrators can be effective when two units are connected together to achieve adequate flow rates 5

Preventive Treatment Algorithm

For Episodic Cluster Headache

  • Galcanezumab is the first-line prophylactic treatment based on the strongest evidence among available options according to VA/DoD and American Academy of Neurology guidelines 1, 2

  • Monitor for injection site reactions and hypersensitivity with galcanezumab 2

  • Verapamil at daily doses of at least 240 mg is commonly used for prevention, though guideline evidence is weaker than for galcanezumab; maximum dose depends on efficacy and tolerability 1, 4

For Chronic Cluster Headache

  • Do NOT use galcanezumab for chronic cluster headache (attacks >1 year without remission)—guidelines specifically recommend against it 2

  • Verapamil remains an option, though evidence is insufficient for strong recommendations 1, 2

  • Alternative preventive options include lithium and topiramate 4

Bridge Therapy (Until Prophylaxis Takes Effect)

  • Oral corticosteroids: Use at least 100 mg prednisone (or equivalent) daily, or up to 500 mg IV per day over 5 days 4

  • Greater occipital nerve block with local anesthetic and corticosteroid provides rapid transitional relief 4, 6

Non-Pharmacologic Options

  • Noninvasive vagus nerve stimulation is effective for short-term treatment of episodic cluster headache but not chronic cluster headache 1, 4, 6

Key Clinical Distinctions

Episodic vs. Chronic Cluster Headache

  • Episodic cluster headache: Attack periods lasting weeks to months with remission periods
  • Chronic cluster headache: Attacks occurring for >1 year without remission or with remission periods <3 months
  • This distinction is critical because galcanezumab is effective only for episodic cluster headache 2, 4

Common Pitfalls

  • Do not confuse acute and prophylactic treatments—oxygen and triptans are for individual attacks, not prevention 2

  • Ensure proper oxygen delivery equipment; standard nasal cannulas cannot deliver the required 12 L/min flow rate 1

  • Oral triptans are inadequate for cluster headache due to slow onset; only subcutaneous sumatriptan or intranasal zolmitriptan provide sufficiently rapid relief 1, 6

References

Guideline

Cluster Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Prophylactic Treatment for Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.